Disruptive BRCA1/2 variants are associated with a predisposition to breast and ovarian cancer, and although at a lower frequency, prostate, pancreas and other cancer types are also linked to pathogenic BRCA1/2 variants. This evidence concerns the gene BRCA1 and ovarian carcinoma.